We are pleased to welcome Dr. Paul Bray to the faculty in the Division of Hematology and Hematologic Malignancies. He received his MD degree from the University of Utah in 1977, where he did research with Drs. George Cartwright and Corwin Edwards on hemochromatosis. He did his Internal Medicine Residency at Baylor College of Medicine in Houston, Texas, followed by a Hematology/Oncology Fellowship at the University of California in San Francisco (UCSF). He was on the Hematology faculty at Johns Hopkins University School of Medicine from 1990-2000 and served as Medical Director of the Special Coagulation Laboratory. In 2000 was recruited to Baylor College of Medicine as the first Chief of a new Section of Thrombosis Research, where he developed a world-class program. Dr. Bray was subsequently recruited to the Jefferson Medical College as the 6th Director of the Cardeza Foundation for Hematologic Research and Director of Hematology. He also served as the Director of the Cardeza Special Hemostasis Laboratory and the Associate Vice Chair of Research for the Department of Medicine. He has served in numerous national and international advisory positions, NIH review panels and committees for the American Society of Hematology and the International Society of Thrombosis and Haemostasis (ISTH). He is a charter member and co-Chair of the ISTH Scientific Subcommittee Genomics in Thrombosis and Hemostasis. He has an extensive track-record of educational successes, having trained more than 25 postdoctoral fellows, graduate students, Hem/Onc fellows and junior faculty. He has given scores of national and international invited lectures. Dr. Bray has had 30 years of continuous funding from the National Institutes of Health (NIH) and currently is PI on three NIH R01 grants. Dr. Bray’s laboratory performs basic and translational research on 1) the role of platelets in inherited and acquired disorders of hemostasis, thrombosis and cardiovascular disease, 2) genomic and transcriptomic approaches to identification of novel genes and gene variants involved in platelet reactivity and pharmacogenetics, and 3) the role of platelet microRNAs (and other non-coding RNAs) on platelet gene expression and physiology, and 4) the molecular mechanisms by which these genes and transcripts regulate platelet thrombus formation. He has published more than 160 peer-reviewed papers, book chapters and invited reviews. Dr. Bray is a clinical Hematologist who cares for out-patients with non-malignant hematology disorders. We welcome Dr. Bray to our faculty.
Nov 07, 2016